A detailed history of Fragasso Group Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Fragasso Group Inc. holds 5,994 shares of ABT stock, worth $687,871. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,994
Previous 6,023 0.48%
Holding current value
$687,871
Previous $625,000 9.28%
% of portfolio
0.06%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$100.07 - $118.13 $2,902 - $3,425
-29 Reduced 0.48%
5,994 $683,000
Q2 2024

Jul 08, 2024

BUY
$100.73 - $112.44 $23,671 - $26,423
235 Added 4.06%
6,023 $625,000
Q1 2024

Apr 10, 2024

BUY
$109.52 - $120.96 $17,851 - $19,716
163 Added 2.9%
5,788 $657,000
Q4 2023

Jan 08, 2024

BUY
$90.19 - $110.4 $15,422 - $18,878
171 Added 3.14%
5,625 $619,000
Q3 2023

Dec 06, 2023

SELL
$95.53 - $114.62 $382 - $458
-4 Reduced 0.07%
5,454 $528,000
Q2 2023

Jul 10, 2023

SELL
$100.78 - $112.29 $7,356 - $8,197
-73 Reduced 1.32%
5,458 $595,000
Q1 2023

Apr 13, 2023

BUY
$96.86 - $114.01 $12,010 - $14,137
124 Added 2.29%
5,531 $560,000
Q4 2022

Jan 24, 2023

SELL
$95.06 - $111.52 $513,989 - $602,988
-5,407 Closed
0 $0
Q4 2022

Jan 24, 2023

SELL
$95.06 - $111.52 $5,323 - $6,245
-56 Reduced 1.03%
5,407 $0
Q3 2022

Oct 13, 2022

BUY
$96.76 - $112.03 $19,545 - $22,630
202 Added 3.84%
5,463 $529,000
Q2 2022

Aug 30, 2022

BUY
$102.07 - $123.37 $1,837 - $2,220
18 Added 0.34%
5,261 $572,000
Q1 2022

Apr 06, 2022

BUY
$114.02 - $139.04 $1,710 - $2,085
15 Added 0.29%
5,243 $621,000
Q4 2021

Jan 19, 2022

SELL
$115.53 - $141.46 $79,253 - $97,041
-686 Reduced 11.6%
5,228 $736,000
Q3 2021

Oct 08, 2021

BUY
$116.66 - $129.06 $69,179 - $76,532
593 Added 11.14%
5,914 $699,000
Q2 2021

Jul 19, 2021

BUY
$105.79 - $124.53 $2,221 - $2,615
21 Added 0.4%
5,321 $617,000
Q1 2021

May 27, 2021

BUY
$108.84 - $128.23 $9,033 - $10,643
83 Added 1.59%
5,300 $635,000
Q4 2020

Feb 04, 2021

BUY
$105.0 - $114.42 $1,260 - $1,373
12 Added 0.23%
5,217 $571,000
Q3 2020

Nov 05, 2020

BUY
$91.64 - $111.29 $1,374 - $1,669
15 Added 0.29%
5,205 $566,000
Q2 2020

Aug 10, 2020

BUY
$76.57 - $98.0 $1,301 - $1,666
17 Added 0.33%
5,190 $525,000
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $3,266 - $4,776
-52 Reduced 1.0%
5,173 $408,000
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $6,673 - $7,429
85 Added 1.65%
5,225 $454,000
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $1,309 - $1,419
16 Added 0.31%
5,140 $430,000
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $1,311 - $1,530
18 Added 0.35%
5,124 $431,000
Q1 2019

May 08, 2019

BUY
$66.22 - $80.06 $1,191 - $1,441
18 Added 0.35%
5,106 $408,000
Q4 2018

Feb 12, 2019

BUY
$65.56 - $74.27 $1,048 - $1,188
16 Added 0.32%
5,088 $368,000
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $25,418 - $30,664
418 Added 8.98%
5,072 $357,000
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $3,094 - $3,499
55 Added 1.2%
4,654 $279,000
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $221,027 - $246,690
4,599
4,599 $245,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fragasso Group Inc. Portfolio

Follow Fragasso Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.